Sep. 21, 2009 (Business Wire) -- First graph, first sentence of release should read: The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Wednesday, September 23. (sted: September 24).
The corrected release reads:
UBS GLOBAL LIFE SCIENCES CONFERENCE OPENS IN NEW YORK
The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Wednesday, September 23. The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 2,000 people are expected to attend. Presenting companies include:
| Actelion Pharmaceuticals Ltd. | | DENTSPLY International | | Pall Corporation |
| Agilent Technologies, Inc. | | Eli Lilly and Company | | PharMerica Corporation |
| Alcon, Inc. | | F. Hoffmann - La Roche Ltd. | | QIAGEN N.V. |
| Alexion Pharmaceuticals, Inc. | | Genzyme Corporation | | Quality Systems, Inc. |
| Allergan, Inc. | | Gilead Sciences, Inc. | | ResMed Inc. |
| Allscripts-Misys Healthcare Solutions, Inc. | | Hospira, Inc. | | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| AstraZeneca PLC | | Human Genome Sciences Inc. | | Sigma-Aldrich Corporation |
| Biogen Idec Inc. | | Illumina, Inc. | | Smith & Nephew plc |
| BioMed Realty Trust Inc. | | IMS Health, Inc. | | Stericycle, Inc. |
| bioMerieux SA | | Intuitive Surgical, Inc. | | Stryker Corporation |
| Cardinal Health, Inc. | | Laboratory Corporation of America Holdings | | Teva Pharmaceutical Industries Limited |
| CareFusion Corporation | | Life Technologies Corporation | | Thermo Fisher Scientific Inc. |
| Celgene Corporation | | Merck & Co., Inc. | | Vertex Pharmaceuticals Incorporated |
| Cephalon Corporation | | Mettler-Toledo International Inc. | | Zimmer Holdings, Inc. |
| Charles River Laboratories International, Inc. | | Millipore Corporation | | |
| Covance Inc. | | Mylan Inc. | | |
| Danaher Corporation | | Myriad Genetics, Inc. | | |
| | | Novartis AG | | |
*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences.
Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.
Headquartered in Zurich and Basel, Switzerland, UBS is one of the world's leading financial firms. It serves a discerning, international client base with its wealth management, investment banking and asset management businesses. In Switzerland, UBS is the market leader in retail and commercial banking.
UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 38% of its employees working in the Americas, 34% in Switzerland, 15% in the rest of Europe and 13% in Asia Pacific. UBS employs more than 75,000 people around the world. Its shares are listed on the SIX Swiss Exchange, the New York Stock Exchange (NYSE) and the Tokyo Stock Exchange (TSE).
